Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma
Su Yin Lim, Elena Shklovskaya, Jenny Lee, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

A Smart DNA Hydrogel Enables Synergistic Immunotherapy and Photodynamic Therapy of Melanoma
Sen Yang, Junlin Wu, Zhongyu Wang, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 14
Closed Access | Times Cited: 15
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Martin Lauss, Bengt Phung, Troels Holz Borch, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Single-cell RNA sequencing in melanoma: what have we learned so far?
Su Yin Lim, Helen Rizos
EBioMedicine (2024) Vol. 100, pp. 104969-104969
Open Access | Times Cited: 11
Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy
Francisco Meraz-Torres, Heike Niessner, Sarah Plöger, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 8
Epigenetic regulation of tumor immunity
Lizhi Pang, Fei Zhou, Yang Liu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 12
Open Access | Times Cited: 8
Succinate Nanomaterials Boost Tumor Immunotherapy via Activating Cell Pyroptosis and Enhancing MHC-I Expression
Pan Zheng, Guanglei Wang, Bin Liu, et al.
Journal of the American Chemical Society (2025)
Open Access | Times Cited: 1
PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer models
Chun Wai Wong, Christos Evangelou, Kieran N. Sefton, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Determinants of resistance and response to melanoma therapy
Bailey M. Robertson, Mitchell E. Fane, Ashani T. Weeraratna, et al.
Nature Cancer (2024) Vol. 5, Iss. 7, pp. 964-982
Closed Access | Times Cited: 7
Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells
Karunakar Saamarthy, Kristofer Ahlqvist, Renée Daams, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
PKC-independent PI3K signalling diminishes PKC inhibitor sensitivity in uveal melanoma
John Park, Sabine Abou Hamad, Ashleigh Stewart, et al.
Oncogenesis (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
The role of extracellular vesicle immune checkpoints in cancer
Weiming Zhang, Mingrong Ou, Ping Yang, et al.
Clinical & Experimental Immunology (2024) Vol. 216, Iss. 3, pp. 230-239
Open Access | Times Cited: 4
Next-Generation Immunotherapy for Hepatocellular Carcinoma: Mechanisms of Resistance and Novel Treatment Approaches
Shabnam Eghbali, Thatcher Heumann
Cancers (2025) Vol. 17, Iss. 2, pp. 236-236
Open Access
Cancer evolution: from Darwin to the Extended Evolutionary Synthesis
Thierry Savy, Lucy Flanders, Thaneswari Karpanasamy, et al.
Trends in cancer (2025)
Open Access
Copper in melanoma: at the crossroad of protumorigenic and anticancer roles
Natalia Chrzan, Mariusz L. Hartman
Redox Biology (2025) Vol. 81, pp. 103552-103552
Open Access
Sex and Age-Based Differences in Immune Responses to a Peptide Vaccine for Melanoma in Two Clinical Trials
Serena M. Vilasi, Craig L. Slingluff
Vaccines (2025) Vol. 13, Iss. 2, pp. 194-194
Open Access
The Application of Dendritic Cells Vaccines in Tumor Therapy and Their Combination with Biomimetic Nanoparticles
Tong Zhu, Yuexin Li, Yutao Wang, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 337-337
Open Access
Deciphering permissivity of human tumor ecosystems to oncolytic viruses
Benjamin Schoeps, Ulrich M. Lauer, Knut Elbers
Oncogene (2025)
Open Access
Targeted Therapy Innovations for Melanoma
Dahiana Amarillo, Keith T. Flaherty, Ryan J. Sullivan
Hematology/Oncology Clinics of North America (2024) Vol. 38, Iss. 5, pp. 973-995
Closed Access | Times Cited: 4
The role of IFN-γ-signalling in response to immune checkpoint blockade therapy
Chun Wai Wong, Yang Huang, Adam Hurlstone
Essays in Biochemistry (2023) Vol. 67, Iss. 6, pp. 991-1002
Open Access | Times Cited: 10
Laser-induced vapor nanobubbles for B16-F10 melanoma cell killing and intracellular delivery of chemotherapeutics
Jana Ramon, Yanou Engelen, Herlinde De Keersmaecker, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 1019-1036
Closed Access | Times Cited: 9
The Role of T-Cadherin (CDH13) in Treatment Options with Garcinol in Melanoma
Sebastian Staebler, Sebastian Hoechst, Aranya Thongmao, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1853-1853
Open Access | Times Cited: 3
Micro/nano system-mediated local treatment in conjunction with immune checkpoint inhibitor against advanced-Stage malignant melanoma
Lu Tang, Hening Liu, Yue Yin, et al.
Chemical Engineering Journal (2024) Vol. 497, pp. 154499-154499
Closed Access | Times Cited: 3
A Smart DNA Hydrogel Enables Synergistic Immunotherapy and Photodynamic Therapy of Melanoma
Sen Yang, Junlin Wu, Zhongyu Wang, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 14
Closed Access | Times Cited: 2
Targeted DNA Sequencing of Cutaneous Melanoma Identifies Prognostic and Predictive Alterations
Alexandra M. Haugh, Robert C. Osorio, R François, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1347-1347
Open Access | Times Cited: 2
Lymphatic system regulation of anti-cancer immunity and metastasis
Pin‐Ji Lei, Cameron Fraser, Dennis Jones, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top